Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
CompletedNCT01096667
Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2, Hypertension
Start: 2010-05-17End: 2011-02-25Updated: 2018-09-13